1. Home
  2. CLBT vs HAE Comparison

CLBT vs HAE Comparison

Compare CLBT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellebrite DI Ltd.

CLBT

Cellebrite DI Ltd.

HOLD

Current Price

$12.81

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$74.43

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBT
HAE
Founded
1999
1971
Country
Israel
United States
Employees
1285
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CLBT
HAE
Price
$12.81
$74.43
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$22.50
$84.13
AVG Volume (30 Days)
2.0M
984.8K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$21.45
N/A
Revenue Next Year
$17.47
$5.23
P/E Ratio
$45.29
$37.52
Revenue Growth
N/A
N/A
52 Week Low
$11.03
$47.32
52 Week High
$19.98
$87.32

Technical Indicators

Market Signals
Indicator
CLBT
HAE
Relative Strength Index (RSI) 44.41 62.97
Support Level $12.65 $48.98
Resistance Level $13.95 $86.72
Average True Range (ATR) 0.71 3.25
MACD -0.14 0.53
Stochastic Oscillator 12.03 55.12

Price Performance

Historical Comparison
CLBT
HAE

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: